Through the genomic actions of vitamin D3 via VDR regulation of several genes containing VDREs, 1α,25(OH)2 vitamin D3 and its analogues inhibit cell cycle progression and tumor cell growth in several cancer cell lines. Here, VDR is linked to neoplasm.